"Trichomonas vaginalis P16 immunoreactivity in cervicovaginal Pap tests: A diagnostic pitfall." by Liron Pantanowitz, MD

Selected Works of Roxanne Florence MD

Follow Contact

Article

Trichomonas vaginalis P16 immunoreactivity in cervicovaginal Pap tests: A diagnostic pitfall.

All Scholarly Works

Liron Pantanowitz, MD, Baystate Health
Christopher Otis, MD, Baystate Health
Robert Goulart, MD, Baystate Health
Roxanne Florence, MD, Baystate Health

Document Type

Article, Peer-reviewed

Publication Date

9-1-2005

Abstract

Detection of p16 is emerging as a useful biomarker for Human Papillomavirus (HPV)-related dysplastic and malignant lesions of the cervix, and as such has potential application to cervicovaginal Papanicolaou (Pap) specimens. While evaluating p16 immunocyto

Publication ISSN

0028-3878

Citation Information

Diagn Cytopathol 2005 Sep;33(3):210-3.